Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IDEAYA Biosciences (IDYA) Cash from Investing Activities (2019 - 2025)

IDEAYA Biosciences' Cash from Investing Activities history spans 7 years, with the latest figure at -$97.5 million for Q4 2025.

  • For Q4 2025, Cash from Investing Activities rose 50.52% year-over-year to -$97.5 million; the TTM value through Dec 2025 reached $70.0 million, up 113.92%, while the annual FY2025 figure was $70.0 million, 113.92% up from the prior year.
  • Cash from Investing Activities for Q4 2025 was -$97.5 million at IDEAYA Biosciences, down from $41.8 million in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at $79.8 million in Q1 2025 and bottomed at -$354.0 million in Q1 2024.
  • The 5-year median for Cash from Investing Activities is -$14.0 million (2022), against an average of -$34.7 million.
  • The largest annual shift saw Cash from Investing Activities plummeted 2388.14% in 2022 before it soared 374.83% in 2023.
  • A 5-year view of Cash from Investing Activities shows it stood at -$413000.0 in 2021, then tumbled by 2388.14% to -$10.3 million in 2022, then plummeted by 989.36% to -$111.9 million in 2023, then tumbled by 76.08% to -$197.1 million in 2024, then surged by 50.52% to -$97.5 million in 2025.
  • Per Business Quant, the three most recent readings for IDYA's Cash from Investing Activities are -$97.5 million (Q4 2025), $41.8 million (Q3 2025), and $45.9 million (Q2 2025).